BlackRock, Inc. 13D and 13G filings for Harmony Biosciences Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-05 1:23 pm Purchase | 2024-12-31 | 13G | Harmony Biosciences Holdings, Inc. HRMY | BlackRock Inc. BLK | 6,968,097 12.200% | 965,723 (+16.09%) | Filing |
| 2024-01-24 2:27 pm Sale | 2023-12-31 | 13G | Harmony Biosciences Holdings, Inc. HRMY | BlackRock Inc. BLK | 6,002,374 10.200% | -129,160 (-2.11%) | Filing |
| 2023-10-06 2:34 pm Purchase | 2023-09-30 | 13G | Harmony Biosciences Holdings, Inc. HRMY | BlackRock Inc. BLK | 6,131,534 10.200% | 1,262,705 (+25.93%) | Filing |
| 2023-02-03 4:27 pm Purchase | 2022-12-31 | 13G | Harmony Biosciences Holdings, Inc. HRMY | BlackRock Inc. BLK | 4,868,829 8.200% | 1,129,063 (+30.19%) | Filing |
| 2022-02-04 4:12 pm Purchase | 2021-12-31 | 13G | Harmony Biosciences Holdings, Inc. HRMY | BlackRock Inc. BLK | 3,739,766 6.400% | 3,739,766 (New Position) | Filing |